Cmo

‘Innovators need to meet contract services partners sooner, plan much earlier and far further into development’

26-Oct-2022 By Rachel Arthur

A ‘significant shift’ is under way in global outsourcing strategies: with the sector moving away from phase-appropriate development in favor of a more forward-looking model – with experts advising starting the search for an outsourcing partner as early...

CPhI Festival of Pharma

CPhI keynote tackles top trends for the CDMO sector

16-Sep-2020 By Jenni Spinner

A session at the upcoming CPhI Festival of Pharma will examine supply chain, clinical trials, digitalization, and other factors impacting the field.

Recro spins out Baudax to boost CDMO focus

28-Nov-2019 By Vassia Barba

Recro Pharma announces the separation of its acute care business to launch Baudax Bio as a developer of products, including non-opioid analgesics, to concentrate on its CDMO business.

Mallinckrodt looks to grow CMO business to offset opioid headwind

12-Nov-2019 By Nick Taylor

Mallinckrodt talks up prospect of contract manufacturing growth offsetting opioid headwind faced by its speciality generics business.

Early manufacturing life-saving for biologics developers, says CMO exec

23-Sep-2019 By Vassia Barba

‘Talk to your CDMO early’ is the advice BioConnection gives to developers of biopharmaceuticals, suggesting that they make a reservation to ensure availability.

NanoComposix adds drug manufacturing to services roster

13-Jun-2019 By Melissa Fassbender

San Diego, CA-based NanoComposix received its drug manufacturing license which it said will ensure clients are able to use one vendor throughout the product life cycle.

Cambrex continues build-out at former PharmaCore site with $1m investment

11-Dec-2018 By Melissa Fassbender

Cambrex is investing $1m at its High Point, NC-based site, marking the most recent in a series of investments which will see the addition of 1,300 square feet and 15 new employees.

Blockchain could solve many challenges facing the clinical trials process: Analyst

20-Nov-2018 By Melissa Fassbender

Blockchain provides real-time visibility into the entire clinical trial supply chain and has the potential to solve several of the industry’s biggest challenges.

Sharp inks preferred partnership with CMO to reduce clinical trial complexity

08-Nov-2018 By Melissa Fassbender

Sharp has signed a preferred partnerships agreement with an MA-based CMO to reduce “friction” for clients while decreasing the time, cost, and complexity of managing clinical trials.